 | Up a level |
Journal Article
Mueller, Dirk, Danner, Marion 
ORCID: 0000-0002-0653-4092, Rhiem, Kerstin, Stollenwerk, Björn ORCID: 0000-0002-3189-409X, Engel, Christoph ORCID: 0000-0002-7247-282X, Rasche, Linda, Borsi, Lisa, Schmutzler, Rita K. ORCID: 0000-0001-8160-4348 and Stock, Stephanie ORCID: 0000-0002-1726-9300
(2018).
Cost-effectiveness of different strategies to prevent breast and ovarian cancer in German women with a BRCA 1 or 2 mutation.
Eur. J. Health Econ., 19 (3).
S. 341 - 354.
NEW YORK:
SPRINGER.
ISSN 1618-7601
Mueller, Dirk, Fischer, Kirsten, Kaiser, Peter, Eichhorst, Barbara, Walshe, Ronald, Reiser, Marcel, Kellermann, Lenka, Borsi, Lisa, Civello, Daniele, Mensch, Alexander, Bahlo, Jasmin, Hallek, Michael, Stock, Stephanie and Fingerle-Rowson, Guenter (2016). Cost-effectiveness of rituximab in addition to fludarabine and cyclophosphamide (R-FC) for the first-line treatment of chronic lymphocytic leukemia. Leuk. Lymphoma, 57 (5). S. 1130 - 1140. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403